Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ: MRVI )

2.410 -0.010 (-0.41%)
Streaming Delayed Price Updated: 12:19 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Law Offices of Howard G. Smith Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
MRVI CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc.
From The Law Offices of Frank R. Cruz
Via Business Wire
Earnings Scheduled For February 25, 2025
Via Benzinga
4 Analysts Have This To Say About Maravai LifeSciences
Via Benzinga
Decoding 5 Analyst Evaluations For Maravai LifeSciences
Via Benzinga
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
From Faruqi & Faruqi, LLP
Via Business Wire
MRVI Class Action Notice: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Maravai LifeSciences Holdings, Inc. Investors
From Glancy Prongay & Murray LLP
Via Business Wire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Maravai Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MRVI INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Maravai LifeSciences Holdings, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Maravai LifeSciences Securities Fraud Investigation: Investors Urged to Contact Award-Winning Firm, Gibbs Law Group LLP
From Gibbs Law Group
Via Business Wire
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
From TriLink BioTechnologies
Via Business Wire
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
From Maravai LifeSciences, Inc.
Via Business Wire
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
Via Benzinga
Exposures Fossil Fuels
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Announces Earnings Release Date 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
From Maravai LifeSciences, Inc.
Via Business Wire
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.